{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:11:37Z","timestamp":1778667097932,"version":"3.51.4"},"reference-count":17,"publisher":"Termedia Sp. z.o.o.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"DOI":"10.5114\/aoms\/221422","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:21:06Z","timestamp":1778664066000},"page":"782-784","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular disease in cancer patients: a neglected dimension of modern oncology"],"prefix":"10.5114","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7803-5850","authenticated-orcid":false,"given":"Seyed Saeed","family":"Tamehri Zadeh","sequence":"first","affiliation":[{"name":"Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":true,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, John Paul II Catholic University of Lublin (KUL), Lublin, Poland"},{"name":"Department of Preventive Cardiology and Lipidology, Medical University of Lodz (MUL), Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref-1859557","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74: 229-63.","DOI":"10.3322\/caac.21834"},{"key":"ref-1859558","doi-asserted-by":"crossref","unstructured":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. J Am Coll Cardiol 2025; 86: 2167-43.","DOI":"10.1016\/j.jacc.2025.08.015"},{"key":"ref-1859559","doi-asserted-by":"crossref","unstructured":"Alhuneafat L, Guha A, Blaes A, Konety SH. Cancer and cardiovascular disease: shared risk factors, mechanisms, and clinical implications: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol 2025; 7: 453-69.","DOI":"10.1016\/j.jaccao.2025.07.001"},{"key":"ref-1859560","doi-asserted-by":"crossref","unstructured":"Gao S, Zhu H, Chang X, et al. Cardiovascular death risk in patients with solid tumors: a population-based study in the United States. Eur J Cancer Prev 2025; 34: 11-23.","DOI":"10.1097\/CEJ.0000000000000921"},{"key":"ref-1859561","doi-asserted-by":"crossref","unstructured":"Styczkiewicz K, Lewicka E, Bielecka-D\u0105browa A, et al. Principles of primary prevention of cardiovascular diseases in patients with cancer. Expert Opinion of the Working Group on Prevention and Epidemiology (Cardio-oncology Task Force) and the Working Group on Cardio-oncology of the Polish Cardiac Society. Pol Heart J 2026; 84: 131-56.","DOI":"10.33963\/v.phj.109247"},{"key":"ref-1859562","doi-asserted-by":"crossref","unstructured":"Zullig LL, Sung AD, Khouri MG, et al. Cardiometabolic comorbidities in cancer survivors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 2022; 4: 149-65.","DOI":"10.1016\/j.jaccao.2022.03.005"},{"key":"ref-1859563","doi-asserted-by":"crossref","unstructured":"Dyrbu\u015b K, Banach M, Gil R, et al. Interdisciplinary expert team statement on the treatment of multi-bed atherosclerotic disease \u2013 endorsed by Polish Cardiac Society, Polish Lipid Association, Polish Society of Diabetology, Polish Neurological Society, Polish Society of Nephrology. Pol Heart J 2025; 83: 531-9.","DOI":"10.33963\/v.phj.105235"},{"key":"ref-1859564","doi-asserted-by":"crossref","unstructured":"Vi\u00f1as-Mendieta AE, Gallardo-Grajeda A, L\u00f3pez-Fern\u00e1ndez T. Cardio-oncology: chances and challenges. Basic Res Cardiol 2025; 120: 3-9.","DOI":"10.1007\/s00395-024-01080-y"},{"key":"ref-1859565","doi-asserted-by":"crossref","unstructured":"Qiu X, Hu B, Ke J, Gu J. Global co-occurrence patterns of cancer and cardiovascular disease: a comprehensive analysis based on the Global Burden of Disease Study 2021. Arch Med Sci 2026; 22: 760-81.","DOI":"10.5114\/aoms\/216397"},{"key":"ref-1859566","doi-asserted-by":"crossref","unstructured":"Ahmad J, Muthyala A, Kumar A, Dani SS, Ganatra S. Disparities in cardio-oncology: effects on outcomes and opportunities for improvement. Curr Cardiol Rep 2022; 24: 1117-27.","DOI":"10.1007\/s11886-022-01732-2"},{"key":"ref-1859567","doi-asserted-by":"crossref","unstructured":"Banach M, Mastalerz-Migas A, Wita K, My\u015bliwiec M. Poland takes a lead in effective lipid disorders management healthcare programmes in Europe. Am J Prev Cardiol 2025; 24: 101346.","DOI":"10.1016\/j.ajpc.2025.101346"},{"key":"ref-1859568","doi-asserted-by":"crossref","unstructured":"Ganjali S, Banach M, Pirro M, Fras Z, Sahebkar A. HDL and cancer-causality still needs to be confirmed? Update 2020. Semin Cancer Biol 2021; 73: 169-77.","DOI":"10.1016\/j.semcancer.2020.10.007"},{"key":"ref-1859569","doi-asserted-by":"crossref","unstructured":"Freihat O, Sipos D, Aamir M, Kovacs A. Global burden and future projections of non-communicable diseases (2000\u20132050): progress toward SDG 3.4 and disparities across regions and risk factors. PLoS One 2025; 20: e0336036.","DOI":"10.1371\/journal.pone.0336036"},{"key":"ref-1859570","doi-asserted-by":"crossref","unstructured":"Banach M. No time to wait: daily step counts should be incorporated into physical activity guidelines. Arch Med Sci 2025; 21: 2164-7.","DOI":"10.5114\/aoms\/210673"},{"key":"ref-1859571","doi-asserted-by":"crossref","unstructured":"Banach M, Fogacci F, Atanasov AG, et al. A 360 perspective on cardiovascular prevention: the International Lipid Expert Panel SiMple tIps for the heaLthy hEart (ILEP-SMILE). Arch Med Sci 2025; 21: 711-8.","DOI":"10.5114\/aoms\/205732"},{"key":"ref-1859572","doi-asserted-by":"crossref","unstructured":"Ding D, Nguyen B, Nau T, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. Lancet Public Health 2025; 10: e668-81.","DOI":"10.1016\/S2468-2667(25)00164-1"},{"key":"ref-1859573","doi-asserted-by":"crossref","unstructured":"TamehriZadeh SS, Khalaji M, Tajdari M, et al. Statins: novel approaches for the management of doxorubicin-induced cardiotoxicity \u2013 a literature review. Cardiovasc Toxicol 2025; 25: 1429-52.","DOI":"10.1007\/s12012-025-10030-6"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-221422-139814","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-221422-139814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:22:11Z","timestamp":1778664131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/Cardiovascular-disease-in-cancer-patients-a-neglected-dimension-of-modern-oncology,221422,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"alternative-id":["221422"],"URL":"https:\/\/doi.org\/10.5114\/aoms\/221422","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}